The results showed that there was an influence of hypertriglyceridemia during midlife (40–60 years of age) on late-onset AD risk in APOE e4 negative participants, after adjustment for systolic blood pressure and based on genetic markers [46]. Here, APOE is linked to Alzheimer disease.